Recent Research Funding

Michael E. Duffey, PhD.

For decades, National Institutes of Health funding has supported Michael E. Duffey, PhD, whose work has been published in top journals such as Nature.

We receive funding from a variety of sources that recognize the value of our high-impact research.

  • Synaptic and Genetic Mechanisms of Sex-Specific Effects of Stress. Zhen Yan (Principal Investigator). NIH. $2,621,841. 4/1/2021-1/1/2026.
  • Immunomodulatory Therapy After Resuscitation From Cardiac Arrest. Brian Weil (Principal Investigator). National Institutes of Health (NHLBI). $1,822,516. 1/1/2022-12/1/2025.
  • Investigating the role of NBCe1-B in renal and cardiac acid-base handling. Mark Parker (Consultant). NIH. 7/1/2020-7/1/2025.
  • Molecular Segregation of Parkinson’s Disease by Patient-derived Neurons. Jian Feng (Principal Investigator). NINDS/NIH. $2,244,925. 6/1/2020-5/1/2025.
  • Preventing and Reversing Interstitial Fibrosis in HFpEF. Brian Weil (Co-Investigator). Veteran's Affairs Merit Review Award. $709,984. 10/1/2020-9/1/2024.
  • Renal considerations in the heat stress and hydration recommendations. Mark Parker (Co-Investigator). NIH National Institute for Occupational Safety and Health. 9/1/2019-8/1/2024.
  • Targeting Histone K4 Methylation for Treatment of Alzheimer's Disease and Related Dementia. Zhen Yan (Principal Investigator). NIH. $2,532,180. 8/1/2019-3/1/2024.
  • Role of epicardial adiposity as a local mediator of VT/VF dynamics in donor human hearts. Kedar Aras (Principal Investigator). NIH/NHLBI. $198,272. 5/1/2020-4/1/2023.
  • Fluorescent peptides for probing and modulation of membrane mechanics. Thomas Suchyna (Principal Investigator). NIGMS. 4/1/2020-3/1/2023.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Michael Duffey (Co-Investigator). NIH National Eye Institute. $1,972,804. 2/1/2018-1/1/2023.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Mark Parker (Principal Investigator). NEI. 1/1/2018-1/1/2023.
  • Investigation of Myocardial Sympathetic Denervation as a Novel Mechanism of Ischemia-Induced Pulseless Electrical Activity Cardiac Arrest. Brian Weil (Principal Investigator). The ZOLL Foundation. $47,740. 1/1/2022-12/1/2022.
  • Pathophysiology of Left Ventricular Stiffening in Heart Failure. Brian Weil (Principal Investigator). National Institutes of Health (NHLBI). $397,476. 9/1/2020-8/1/2022.
  • Role of myosin IC in prostate cancer metastasis. Wilma Hofmann (Principal Investigator). NIH/NCI. $478,500. 8/1/2017-7/1/2022.
  • A Novel Epigenetic Mechanism for Alzheimer's Disease. Jian Feng (Co-Investigator), Zhen Yan (Principal Investigator). NIH. $1,993,750. 4/1/2017-3/1/2022.
  • New Treatment Strategy for Alzheimer's Disease. Zhen Yan (Co-Principal Investigator). NIH. $438,625. 4/1/2020-3/1/2022.
  • Functions of parkin in Parkinson’s disease. Jian Feng (Principal Investigator). NINDS/NIH. $1,801,304. 9/1/2018-3/1/2022.
  • Kinetic Barriers of Transdifferentiation. Jian Feng (Principal Investigator). Department of Veterans Affairs. $833,012. 4/1/2018-3/1/2022.
  • The Interaction of parkin and environmental toxins in Parkinson’s disease. Jian Feng (Principal Investigator). Department of Veterans Affairs. $783,012. 3/1/2018-3/1/2022.
  • New Treatment Strategy for Alzheimer’s Disease. Jian Feng (Principal Investigator). NIA/NIH. $438,625. 4/1/2020-3/1/2022.